Opioid and Neuropathic Use After Initiating btsDMARDs in RA Dr. Julian Segan ( @JulianSegan) discusses Abstract 0925 at #ACR22 https://t.co/H6g3zKQIlF https://t.co/sQp2pyiOTb

Treatment Considerations in Axial Spondyloarthritis Dr. Lianne Gensler discusses treatment considerations in Axial SpA from #ACR22. -Abstract 0402 -Abstract 0388 -Abstract 0544 -Abstract 0545 https://t.co/kaPFMfchYG https://t.co/ll8HWutyLo

Can we alter neonatal gut microbiome to prevent spondyloarthritis? Dr Chao ( @doctorRBC) discusses Abstract 0868 at the #ACR22. Abstract 0868: Spondyloarthritis and Neonatal Factors Affecting the Gut Microbiome https://t.co/1rlUWXbWjJ https://t.co/MRoOY0nGop

Updates on Reproductive Health in Women with SLE Dr. Catherine Sims ( @DrCassySims) summarizes reproductive health abstracts presented at #ACR22. https://t.co/Vr8tD5sUfm https://t.co/xPm5Q1N5Ue

New Treatments for SLE? Dr. Petri discusses abstract 1117 presented at #ACR22. Efficacy & Safety of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Patients w/Active SLE: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study https://t.co/O25Fd8B4dT https://t.co/bbuzaiEb8h

Treatment Choices and Mortality in RA-ILD Dr. Julian Segan ( @JulianSegan) talks with Dr. Bryant England about abstract 0245 presented at #ACR22. https://t.co/5GTeZ6i43W https://t.co/t8E5TAJFxu

A Year in Review Dr. Jack Cush reports on highlights from this annual session - featuring Drs. Carol Langford and John Varga as discussants. #ACR22 https://t.co/RcBKzt50ky https://t.co/nyDHX9vqzz

Differences in Presentation and Outcomes of Early vs Late Onset PsA Dr. Petryna ( @DrPetryna) discusses abstract 0377 presented at #ACR22. Abstract 0377: Differences in Early-onset vs. Late-onset PsA: Data from the RESPONDIA and REGISPONSER Studies https://t.co/Bw3RHp3lSR https://t.co/Yva84Iw8hk

What's Happening on the Hill? Dr. Rachel Tate ( @uptoTate) talks with Dr. Angus Worthing about #ACR22 Convergence Session # 12S119 about legislative updates. https://t.co/zd6SVtSqrc https://t.co/7Y8ylkTSbx

Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor Dr. Sims ( @DrCassySims) discusses abstract 0199 presented at #ACR22. https://t.co/L14WoimRE6 https://t.co/LhgyE1LwGa

RA Topic Panel RheumNow recaps the best & most interesting data presented at #ACR22 in RA. Panelists: Drs.Conway, Najm, Liew, Pope, Segan Follow: @RichardPAConway @AurelieRheumo @drdavidliew @Janetbirdope @JulianSegan https://t.co/6SAlQwcPS0 https://t.co/kSZgTQs6Ns

Infections in pre-RA: a cause or a consequence? Dr. Aurelie Najm ( @AurelieRheumo) discusses oral presentation abstract #0535 from #ACR22. https://t.co/ajI2zo4KRA https://t.co/cHkzNshVcn